NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Elisabeth Diver, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Suzanne George, Robert Giuntoli, Ernest Han, Brooke E. Howitt, Warner K. Huh, Jayanthi Lea, Andrea Mariani, David G. Mutch, Larissa Nekhlyudov, Mirna Podoll, Steven W. Remmenga, R. Kevin Reynolds, Ritu Salani, Rachel Sisodia, Pamela T. Soliman, Edward J. Tanner, Stefanie Ueda, Renata R. Urban, Stephanie L. Wethington, Emily Wyse, Kristine Zanotti, Nicole R. McMillian, Angela D. Motter
Abstract
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.